Business Segments · Interest Income

Reportable Segment — Interest Income

Amgen Reportable Segment — Interest Income increased by 15.1% to $99.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 21.4%, from $126.00M to $99.00M.

Analysis

StatementSegment
First reportedQ1 2024
Last reportedQ3 2025
Rolls up toInterest Income
Metric ID: amgn_segment_reportable_segment_interest_income

Historical Data

6 periods
 Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25
Value$153.00M$115.00M$126.00M$126.00M$86.00M$99.00M
QoQ Change—-24.8%+9.6%+0.0%-31.7%+15.1%
YoY Change———-17.6%-25.2%-21.4%
Range$86.00M – $153.00M
CAGR-29.4%
Avg YoY Growth-21.4%
Median YoY Growth-21.4%

Frequently Asked Questions

What is Amgen's reportable segment — interest income?
Amgen (AMGN) reported reportable segment — interest income of $99.00M in Q3 2025.
How has Amgen's reportable segment — interest income changed year-over-year?
Amgen's reportable segment — interest income decreased by 21.4% year-over-year, from $126.00M to $99.00M.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.